Mol Aspects Med (2021) 77:100897
AuNPs are widely developed INPs with excellent biocompatibility and low toxicity
Contrave side effects are primarily neurological: nausea (33%), headache (18%), insomnia (9%), dizziness (10%), and dry mouth (8%)
Expert Opin Investig Drugs 32(5):355359 Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Unlike full-length growth hormone, which can stimulate appetite through IGF-1 production and growth hormone receptor activation, AOD-9604 does not activate the growth hormone/IGF-1 pathway
Effects of exercise interventions to reduce chemotherapy-induced peripheral neuropathy severity: A meta-analysis